搜尋結果
2011年9月26日 · Duxaril Tablets, also known as Compound Almitrine Tablets, containing almitrine bismesylate 30mg and raubasine 10mg, is used for treatment of the symptoms of cognitive and chronic sensorineural impairment in elderly (excluding Alzheimer’s
患有肝性腦病的人士需要確保每天有多於一次排便。. 乳果糖需要一至兩天才能見效。. 若要即時舒緩 便秘 的症狀，可使用其他瀉藥。. 常見服用時間：. 可以在空肚或飽肚時服用。. 資料只供參考，實際服藥時間會因應個人情況做出調整。. 常見可能相沖藥物 ...
國家食品藥品監督管理局撤銷“都可書"(Duxaril)的註冊 謹請閣下垂注國家食品藥品監督管理局發出通知，決定停止“都可喜"(通用名為阿米三 噱蘿巴新片，叉名複方阿米三嗓片)在國內的生產、銷售和使用，撤銷其批准證明檔。
Almitrine (marketed as Duxil by Servier) is a diphenylmethylpiperazine derivative classified as a respiratory stimulant by the ATC. It enhances respiration by acting as an agonist of peripheral chemoreceptors located on the carotid bodies. The drug increases arterial oxygen tension while decreasing arterial carbon dioxide tension in ...
2022年3月13日 · Duxaril is a typical antipsychotic drug of the thioxanthene (tricyclic) class. Duxaril exerts strong blocking effects by blocking the 5-HT2 D1, D2, D3, histamine H1, muscarinic and alpha1 adrenergic receptors.
DUXARIL No product found Added to Your Shopping Cart Back Product Availability by Store Location Previous Next-from stores found Get the latest news and offers. Subscribe to the Mannings' newsletter*. *By clicking the "Subscribe", you agree to Mannings's ...
Cerebral ischemia: from pharmacology to modern techniques and clinical implications. Value of almitrine-raubasin (Duxil Duxaril). International symposium, Hangzhou, People's Republic of China, May 14, 1994
藥劑師 提示: 不要使用超過7天，因為這樣會導致便秘的情況變得更嚴重。. 此藥會在服用後6-12小時起效，在翌晨可順利排便。. 服用制酸劑或 牛奶 後1小時內，請勿服用樂可舒。. 常見服用時間：. 樂可舒應在睡前整粒用水送服。. 不要咀嚼或壓碎藥片。. 資料只 ...
2007年7月24日 · Almitrine is a respiratory stimulant that enhances respiration by acting as an agonist of peripheral chemoreceptors located on the carotid bodies. Mechanism of action. Almitrine is an agonist at the peripheral chemoreceptors expressed on carotid bodies.
2020年6月5日 · The primary end point was the Pa o2 to F io2 ratio between baseline value and peak value during the 1 st through 6 th hour timeframe after introduction of almitrine. The Pa o2 /F io2 ratio was measured with F io2 1. The other endpoints were incidence of treatment failure at 24, 48, 72, and 96 hours, and safety.
